1st Quarter - Report

W STRATEGIES, LLC for GLAXOSMITHKLINE

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.748: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act as it relates to H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act, and H.R.1922: Restoring Access to Medication Act of 2019. Proposed legislation around FDA cosmetics reform. Issues related to oral health.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1922 (116th), H.R. 3433 (116th), H.R. 748 (116th)

Medicare/Medicaid MMM

Regulatory and legislative proposals in the Administrations Blueprint. H.R.3: Lower Drug Costs Now Act of 2019. H.R.19: Lower Costs, More Cures Act of 2019. S.2543: Prescription Drug Pricing Reduction Act of 2019.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 2543 (116th), H.R. 3 (116th), H.R. 19 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.